An Exceedingly Rare Case of Liraglutide-Induced Liver Injury

Swetha Parvataneni; Rajarajeshwari Ramachandran; Eric Then; Tyler Grantham; Vinaya Gaduputi

doi:10.1155/2021/6306149

Case Reports in Gastrointestinal Medicine (Jan 2021)

An Exceedingly Rare Case of Liraglutide-Induced Liver Injury

Swetha Parvataneni,
Rajarajeshwari Ramachandran,
Eric Then,
Tyler Grantham,
Vinaya Gaduputi

Affiliations

Swetha Parvataneni: Department of Internal Medicine, Geisinger Lewistown Hospital, Lewiston, Pennsylvania, USA
Rajarajeshwari Ramachandran: Department of Gastroenterology, Brooklyn Hospital Center, Brooklyn, New York, USA
Eric Then: Department of Gastroenterology, Brooklyn Hospital Center, Brooklyn, New York, USA
Tyler Grantham: St. George’s University, St. George, Grenada
Vinaya Gaduputi: Department of Gastroenterology, Blanchard Valley Health System, Findlay, Ohio, USA

DOI: https://doi.org/10.1155/2021/6306149
Journal volume & issue: Vol. 2021

Abstract

Read online

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

Published in Case Reports in Gastrointestinal Medicine

ISSN: 2090-6528 (Print); 2090-6536 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://www.hindawi.com/journals/crigm/

About the journal